Bruno Quesnel
Overview
Explore the profile of Bruno Quesnel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
4165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lepretre F, Meneboo J, Villenet C, Delestre L, Quesnel B, Shelley C, et al.
Sci Rep
. 2024 Nov;
14(1):28297.
PMID: 39550462
The RhoH protein is a member of the Ras superfamily of guanosine triphosphate-binding proteins. RhoH is an atypical Rho family member that is always GTP-bound and thus always activated. It...
2.
Laguillaumie M, Titah S, Guillemette A, Neve B, Lepretre F, Segard P, et al.
Biol Res
. 2024 Sep;
57(1):59.
PMID: 39223638
Background: Tumour dormancy, a resistance mechanism employed by cancer cells, is a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse. Despite its clinical importance,...
3.
Khamari R, Degand C, Fovez Q, Trinh A, Chomy A, Laine W, et al.
Exp Hematol
. 2024 Jun;
137:104253.
PMID: 38879112
Acute myeloid leukemias are a group of hematological malignancies characterized by a poor prognosis for survival. The discovery of oncogenic mutations in the FMS-like tyrosine kinase 3 (FLT3) gene has...
4.
Lambert M, Jambon S, Bouhlel M, Depauw S, Vrevin J, Blanck S, et al.
Hemasphere
. 2024 May;
8(5):e77.
PMID: 38716146
The mainstay of acute myeloid leukemia (AML) treatment still relies on traditional chemotherapy, with a survival rate of approximately 30% for patients under 65 years of age and as low...
5.
Flechon L, Arib I, Dutta A, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R, et al.
Blood Adv
. 2024 Mar;
8(12):3109-3119.
PMID: 38513135
Mycosis fungoides (MF) is the most prevalent primary cutaneous T-cell lymphoma, with an indolent or aggressive course and poor survival. The pathogenesis of MF remains unclear, and prognostic factors in...
6.
Hasan Bou Issa L, Flechon L, Laine W, Ouelkdite A, Gaggero S, Cozzani A, et al.
iScience
. 2024 Mar;
27(4):109417.
PMID: 38510131
Multiple myeloma (MM) is an incurable hematological malignancy in which MYC alterations contribute to the malignant phenotype. Nevertheless, MYC lacks therapeutic druggability. Here, we leveraged large-scale loss-of-function screens and conducted...
7.
Escure G, Fournier E, Saade C, Hasan Bou Issa L, Arib I, Tilmont R, et al.
Haematologica
. 2023 Oct;
109(4):1289-1292.
PMID: 37855058
No abstract available.
8.
Ben Khoud M, Jouy N, Driss V, Quesnel B, Brinster C
J Interferon Cytokine Res
. 2023 Mar;
43(4):164-172.
PMID: 36927129
Acute myeloid leukemia (AML) is characterized by an increased proliferation and loss of differentiation of hematopoietic myeloid progenitors or precursors. Studies performed in AML-affected patients revealed a T cell deficiency...
9.
Goursaud L, Berthon C, Quesnel B
Br J Haematol
. 2022 Dec;
200(4):e37-e39.
PMID: 36470305
No abstract available.
10.
Gaggero S, Martinez-Fabregas J, Cozzani A, Fyfe P, Leprohon M, Yang J, et al.
Sci Immunol
. 2022 Dec;
7(78):eade5686.
PMID: 36459543
Cytokines interact with their receptors in the extracellular space to control immune responses. How the physicochemical properties of the extracellular space influence cytokine signaling is incompletely elucidated. Here, we show...